Giapreza, a vasoconstrictor, increases blood pressure through increased aldosterone release La Jolla Pharmaceutical announced the availability of Giapreza (angiotesin II) injection for intravenous (IV ...

One in eight patients hospitalized with COVID-19 develop some form of shock, according to the American Heart Association’s COVID-19 Cardiovascular Disease Registry. And regardless of whether the shock ...

Patients in distributive shock appear to have a lower risk for atrial fibrillation when vasopressin is added to catecholamine vasopressors, but its effect on other outcomes are mixed, according to a ...

Shock is the term used to describe the physiologic state when there is tissue hypoperfusion throughout multiple organs. [1] Decreased tissue perfusion leads to decreased tissue oxygen delivery. Early ...